Novel Aptamer-Nanoparticle Bioconjugates Enhances Delivery of Anticancer Drug to MUC1-Positive Cancer Cells In VitroChenchen Yu, Xian‐Da Yang, Wei Yuan et al.|PLoS ONE|2011Cited by 189
<p>Targeted Therapy of Colon Cancer by Aptamer-Guided Holliday Junctions Loaded with Doxorubicin</p>Fengjiao Yao, Xian‐Da Yang, Yacong An et al.|International Journal of Nanomedicine|2020Cited by 38
Selection of a novel DNA aptamer against OFA/iLRP for targeted delivery of doxorubicin to AML cellsYacong An, Xian‐Da Yang, Jinhong Duan et al.|Scientific Reports|2019Cited by 18